Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems.

Cantón R, Oliver A, Alós JI, de Benito N, Bou G, Campos J, Calvo J, Canut A, Castillo J, Cercenado E, Domínguez MÁ, Fernández-Cuenca F, Guinea J, Larrosa N, Liñares J, López-Cerero L, López-Navas A, Marco F, Mirelis B, Moreno-Romo MÁ, Morosini MI, Navarro F, Oteo J, Pascual Á, Pérez-Trallero E, Pérez-Vázquez M, Soriano A, Torres C, Vila J, Martínez-Martínez L.

Enferm Infecc Microbiol Clin. 2019 Mar 13. pii: S0213-005X(19)30135-1. doi: 10.1016/j.eimc.2019.01.017. [Epub ahead of print] Review. English, Spanish.

PMID:
30878313
2.

Molecular characterization of OXA-48 carbapenemase-producing Klebsiella pneumoniae strains after a carbapenem resistance increase in Catalonia.

Argente M, Miró E, Martí C, Vilamala A, Alonso-Tarrés C, Ballester F, Calderón A, Gallés C, Gasós A, Mirelis B, Morta M, Olsina M, Sauca G, Sierra M, Rivera A, Navarro F.

Enferm Infecc Microbiol Clin. 2019 Feb;37(2):82-88. doi: 10.1016/j.eimc.2018.02.003. Epub 2018 Apr 6. English, Spanish.

PMID:
29631930
3.

Is Colistin Susceptibility Testing Finally on the Right Track?

Prim N, Rivera A, Coll P, Mirelis B.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02067-17. doi: 10.1128/AAC.02067-17. Print 2018 Apr. No abstract available.

4.

Prevalence of colistin resistance in clinical isolates of Enterobacteriaceae: A four-year cross-sectional study.

Prim N, Turbau M, Rivera A, Rodríguez-Navarro J, Coll P, Mirelis B.

J Infect. 2017 Dec;75(6):493-498. doi: 10.1016/j.jinf.2017.09.008. Epub 2017 Sep 14.

PMID:
28919348
5.

Intrinsic resistance versus intrinsic resistome: are we talking about the same concept? Reply to 'Resistance to polymyxins in Gram-negative organisms'.

Prim N, Rivera A, Coll P, Mirelis B.

Int J Antimicrob Agents. 2017 Aug;50(2):281. doi: 10.1016/j.ijantimicag.2017.05.004. Epub 2017 Jun 3. No abstract available.

PMID:
28583877
6.

Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride.

Sánchez E, Nieto JC, Vidal S, Santiago A, Martinez X, Sancho FJ, Sancho-Bru P, Mirelis B, Corominola H, Juárez C, Manichanh C, Guarner C, Soriano G.

Sci Rep. 2017 Apr 3;7:45712. doi: 10.1038/srep45712.

7.

Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.

Horcajada JP, Sorlí L, Luque S, Benito N, Segura C, Campillo N, Montero M, Esteve E, Mirelis B, Pomar V, Cuquet J, Martí C, Garro P, Grau S.

Int J Antimicrob Agents. 2016 Dec;48(6):725-727. doi: 10.1016/j.ijantimicag.2016.08.020. Epub 2016 Oct 7.

PMID:
28128096
8.

CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.

Merino I, Shaw E, Horcajada JP, Cercenado E, Mirelis B, Pallarés MA, Gómez J, Xercavins M, Martínez-Martínez L, De Cueto M, Cantón R, Ruiz-Garbajosa P; ITUBRAS-GEIH-SEIMC Group.

J Antimicrob Chemother. 2016 Aug;71(8):2125-30. doi: 10.1093/jac/dkw133. Epub 2016 May 12.

PMID:
27494832
9.

Detection of mcr-1 colistin resistance gene in polyclonal Escherichia coli isolates in Barcelona, Spain, 2012 to 2015.

Prim N, Rivera A, Rodríguez-Navarro J, Español M, Turbau M, Coll P, Mirelis B.

Euro Surveill. 2016;21(13). doi: 10.2807/1560-7917.ES.2016.21.13.30183.

10.

Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.

Alonso N, Miró E, Pascual V, Rivera A, Simó M, Garcia MC, Xercavins M, Morera MA, Espejo E, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E, Navarro F, Mirelis B, Coll P.

Int J Antimicrob Agents. 2016 Jan;47(1):62-8. doi: 10.1016/j.ijantimicag.2015.10.007. Epub 2015 Nov 2.

PMID:
26607336
11.

Efficacy of the FilmArray blood culture identification panel for direct molecular diagnosis of infectious diseases from samples other than blood.

Micó M, Navarro F, de Miniac D, González Y, Brell A, López C, Sánchez-Reus F, Mirelis B, Coll P.

J Med Microbiol. 2015 Dec;64(12):1481-8. doi: 10.1099/jmm.0.000180. Epub 2015 Oct 1.

PMID:
26432445
12.

In Vivo Adaptive Resistance to Colistin in Escherichia coli Isolates.

Prim N, Rivera A, Español M, Mirelis B, Coll P.

Clin Infect Dis. 2015 Nov 15;61(10):1628-9. doi: 10.1093/cid/civ645. Epub 2015 Aug 27. No abstract available.

PMID:
26318913
13.

Effect of long-term acid gastric inhibition on bacterial translocation in cirrhotic rats.

Sánchez E, Soriano G, Mirelis B, Gonzalez B, Nieto JC, Vidal S, Guarner-Argente C, Juárez C, Monés J, Guarner C.

Eur J Gastroenterol Hepatol. 2015 May;27(5):570-6. doi: 10.1097/MEG.0000000000000319.

PMID:
25822866
14.

VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis.

Sánchez E, Nieto JC, Boullosa A, Vidal S, Sancho FJ, Rossi G, Sancho-Bru P, Oms R, Mirelis B, Juárez C, Guarner C, Soriano G.

Liver Int. 2015 Mar;35(3):735-45. doi: 10.1111/liv.12566. Epub 2014 May 12.

PMID:
24750552
15.

[Importance of quality control for the detection of β-lactam antibiotic resistance in Enterobacteriaceae].

Rivera A, Larrosa N, Mirelis B, Navarro F.

Enferm Infecc Microbiol Clin. 2014 Feb;32 Suppl 1:30-6. doi: 10.1016/S0213-005X(14)70147-8. Spanish.

PMID:
24630581
16.

Etiology of surgical site infections after primary total joint arthroplasties.

Benito N, Franco M, Coll P, Gálvez ML, Jordán M, López-Contreras J, Pomar V, Monllau JC, Mirelis B, Gurguí M.

J Orthop Res. 2014 May;32(5):633-7. doi: 10.1002/jor.22581. Epub 2014 Jan 16.

17.

Molecular diagnosis of bloodstream infections with a new dual-priming oligonucleotide-based multiplex PCR assay.

Carrara L, Navarro F, Turbau M, Seres M, Morán I, Quintana I, Martino R, González Y, Brell A, Cordon O, Diestra K, Mata C, Mirelis B, Coll P.

J Med Microbiol. 2013 Nov;62(Pt 11):1673-9. doi: 10.1099/jmm.0.064758-0. Epub 2013 Aug 7.

PMID:
23924662
18.

[Reply to «infections caused by Clostridium difficile. Addendum»].

Rodríguez-Pardo D, Mirelis B, Navarro F.

Enferm Infecc Microbiol Clin. 2013 Oct;31(8):558. doi: 10.1016/j.eimc.2013.04.020. Epub 2013 Jul 6. Spanish. No abstract available.

PMID:
23838212
19.

Modulation of inflammatory response in a cirrhotic rat model with induced bacterial peritonitis.

Sánchez E, Francés R, Soriano G, Mirelis B, Sancho FJ, González-Navajas JM, Muñoz C, Song XY, Pérez-Mateo M, Such J, Guarner C.

PLoS One. 2013;8(3):e59692. doi: 10.1371/journal.pone.0059692. Epub 2013 Mar 20.

20.

Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.

Rodríguez-Pardo D, Almirante B, Bartolomé RM, Pomar V, Mirelis B, Navarro F, Soriano A, Sorlí L, Martínez-Montauti J, Molins MT, Lung M, Vila J, Pahissa A; Barcelona Clostridium difficile Study Group.

J Clin Microbiol. 2013 May;51(5):1465-73. doi: 10.1128/JCM.03352-12. Epub 2013 Feb 27.

21.

[Infections caused by Clostridium difficile].

Rodríguez-Pardo D, Mirelis B, Navarro F.

Enferm Infecc Microbiol Clin. 2013 Apr;31(4):254-63. doi: 10.1016/j.eimc.2012.12.010. Epub 2013 Feb 12. Spanish.

PMID:
23411363
22.

Characterization of aminoglycoside-modifying enzymes in enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion.

Miró E, Grünbaum F, Gómez L, Rivera A, Mirelis B, Coll P, Navarro F.

Microb Drug Resist. 2013 Apr;19(2):94-9. doi: 10.1089/mdr.2012.0125. Epub 2012 Dec 3.

PMID:
23206280
23.

Outbreak of Pseudomonas fluorescens bloodstream infection in a coronary care unit.

Benito N, Mirelis B, Luz Gálvez M, Vila M, López-Contreras J, Cotura A, Pomar V, March F, Navarro F, Coll P, Gurguí M.

J Hosp Infect. 2012 Dec;82(4):286-9. doi: 10.1016/j.jhin.2012.09.008. Epub 2012 Oct 25.

PMID:
23103246
24.

Bloodstream infection due to Brachyspira pilosicoli in a patient with multiorgan failure.

Prim N, Pericas R, Español M, Rivera A, Mirelis B, Coll P.

J Clin Microbiol. 2011 Oct;49(10):3697-9. doi: 10.1128/JCM.00680-11. Epub 2011 Aug 10.

25.

Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis.

Mata C, Navarro F, Miró E, Walsh TR, Mirelis B, Toleman M.

J Antimicrob Chemother. 2011 Oct;66(10):2266-70. doi: 10.1093/jac/dkr286. Epub 2011 Jul 13.

PMID:
21752830
26.

[Detection of resistance phenotypes in gram-negative bacteria].

Navarro F, Calvo J, Cantón R, Fernández-Cuenca F, Mirelis B.

Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):524-34. doi: 10.1016/j.eimc.2011.03.011. Epub 2011 Jun 21. Review. Spanish.

PMID:
21696863
27.

[Interpretive reading of enterobacteria antibiograms].

Navarro F, Miró E, Mirelis B.

Enferm Infecc Microbiol Clin. 2010 Nov;28(9):638-45. doi: 10.1016/j.eimc.2010.05.002. Epub 2010 Jul 1. Review. Spanish.

PMID:
20579780
28.

In vivo transmission of a plasmid coharbouring bla and qnrB genes between Escherichia coli and Serratia marcescens.

Mata C, Miró E, Mirelis B, Garcillán-Barcia MP, de la Cruz F, Coll P, Navarro F.

FEMS Microbiol Lett. 2010 Jul 1;308(1):24-8. doi: 10.1111/j.1574-6968.2010.01980.x. Epub 2010 Apr 8.

29.

Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration.

Coelho A, González-López JJ, Miró E, Alonso-Tarrés C, Mirelis B, Larrosa MN, Bartolomé RM, Andreu A, Navarro F, Johnson JR, Prats G.

Int J Antimicrob Agents. 2010 Jul;36(1):73-8. doi: 10.1016/j.ijantimicag.2010.03.005. Epub 2010 Apr 13.

PMID:
20392607
30.

Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain.

Coelho A, Mirelis B, Alonso-Tarrés C, Nieves Larrosa M, Miró E, Clivillé Abad R, Bartolomé RM, Castañer M, Prats G, Johnson JR, Navarro F, González-López JJ.

J Antimicrob Chemother. 2009 Oct;64(4):862-4. doi: 10.1093/jac/dkp264. Epub 2009 Jul 22. No abstract available. Erratum in: J Antimicrob Chemother. 2010 Aug;65(8):1838.

PMID:
19628471
31.

Prevalence of acquired AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007.

Mata C, Miró E, Rivera A, Mirelis B, Coll P, Navarro F.

Clin Microbiol Infect. 2010 May;16(5):472-6. doi: 10.1111/j.1469-0691.2009.02864.x. Epub 2009 Jun 11.

32.

Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.

Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.

J Antimicrob Chemother. 2009 Apr;63(4):781-4. doi: 10.1093/jac/dkp028. Epub 2009 Feb 17.

PMID:
19223299
33.

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.

Arch Intern Med. 2008 Sep 22;168(17):1897-902. doi: 10.1001/archinte.168.17.1897.

PMID:
18809817
34.

Dissemination of extended-spectrum beta-lactamase-producing bacteria: the food-borne outbreak lesson.

Lavilla S, González-López JJ, Miró E, Domínguez A, Llagostera M, Bartolomé RM, Mirelis B, Navarro F, Prats G.

J Antimicrob Chemother. 2008 Jun;61(6):1244-51. doi: 10.1093/jac/dkn093. Epub 2008 Mar 12.

PMID:
18339635
35.

Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.

Aragón LM, Mirelis B, Miró E, Mata C, Gómez L, Rivera A, Coll P, Navarro F.

J Antimicrob Chemother. 2008 May;61(5):1029-32. doi: 10.1093/jac/dkn056. Epub 2008 Feb 20.

PMID:
18292096
36.

[Recommendations for selecting antimicrobial agents for in vitro susceptibility studies using automatic and semiautomatic systems].

Cantón R, Alós JI, Baquero F, Calvo J, Campos J, Castillo J, Cercenado E, Domínguez MA, Liñares J, López-Cerezo L, Marco F, Mirelis B, Morosini MI, Navarro F, Oliver A, Pérez-Trallero E, Torres C, Martínez-Martínez L; Grupo de Consenso de Recomendaciones para Selección de Antimicrobianos y Concentraciones en Estudio de Sensibilidad in vitro con Sistemas Automáticos y Semiautomáticos.

Enferm Infecc Microbiol Clin. 2007 Jun-Jul;25(6):394-400. Spanish.

PMID:
17583653
37.

Evidence for convergent evolution of CTX-M-14 ESBL in Escherichia coli and its prevalence.

Navarro F, Mesa RJ, Miró E, Gómez L, Mirelis B, Coll P.

FEMS Microbiol Lett. 2007 Aug;273(1):120-3. Epub 2007 Jun 7.

38.

Acquisition and diffusion of bla CTX-M-9 gene by R478-IncHI2 derivative plasmids.

García A, Navarro F, Miró E, Villa L, Mirelis B, Coll P, Carattoli A.

FEMS Microbiol Lett. 2007 Jun;271(1):71-7. Epub 2007 Mar 28.

39.

Clinical and microbiological features of nocardiosis 1997-2003.

Muñoz J, Mirelis B, Aragón LM, Gutiérrez N, Sánchez F, Español M, Esparcia O, Gurguí M, Domingo P, Coll P.

J Med Microbiol. 2007 Apr;56(Pt 4):545-50.

PMID:
17374898
40.

[Relevance of synergism and antagonism phenomena detected among antimicrobial agents with automated systems for antibiogram reading].

Navarro F, Mirelis B.

Enferm Infecc Microbiol Clin. 2007 Feb;25(2):75-6. Spanish. No abstract available.

PMID:
17288903
41.

[Streptococcus agalactiae highly resistant to fluoroquinolones].

Miró E, Rebollo M, Rivera A, Alvarez MT, Navarro F, Mirelis B, Coll P.

Enferm Infecc Microbiol Clin. 2006 Nov;24(9):562-3. Spanish.

PMID:
17125675
42.

Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain.

Rivera A, Rebollo M, Miró E, Mateo M, Navarro F, Gurguí M, Mirelis B, Coll P.

J Med Microbiol. 2006 Aug;55(Pt 8):1115-23.

PMID:
16849733
43.

A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli.

Mirelis B, Rivera A, Miró E, Mesa RJ, Navarro F, Coll P.

Enferm Infecc Microbiol Clin. 2006 Jun-Jul;24(6):370-2.

PMID:
16792938
44.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage).

Mesa RJ, Blanc V, Blanch AR, Cortés P, González JJ, Lavilla S, Miró E, Muniesa M, Saco M, Tórtola MT, Mirelis B, Coll P, Llagostera M, Prats G, Navarro F.

J Antimicrob Chemother. 2006 Jul;58(1):211-5. Epub 2006 May 23.

PMID:
16720567
45.

Prulifloxacin: a new antibacterial fluoroquinolone.

Prats G, Rossi V, Salvatori E, Mirelis B.

Expert Rev Anti Infect Ther. 2006 Feb;4(1):27-41. Review.

PMID:
16441207
46.

Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain.

Miró E, Mirelis B, Navarro F, Rivera A, Mesa RJ, Roig MC, Gómez L, Coll P.

J Antimicrob Chemother. 2005 Dec;56(6):1152-5. Epub 2005 Oct 21.

PMID:
16244084
47.

Characterization of the highly variable region surrounding the bla(CTX-M-9) gene in non-related Escherichia coli from Barcelona.

García A, Navarro F, Miró E, Mirelis B, Campoy S, Coll P.

J Antimicrob Chemother. 2005 Nov;56(5):819-26. Epub 2005 Sep 27.

PMID:
16188915
48.

Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.

Rivera A, Rebollo M, Sánchez F, Navarro F, Miró E, Mirelis B, Coll P.

Clin Microbiol Infect. 2005 Sep;11(9):759-61.

49.

Escherichia coli producing an ACC-1 class C beta-lactamase isolated in Barcelona, Spain.

Miró E, Mirelis B, Navarro F, Matas L, Giménez M, Rabaza C.

Antimicrob Agents Chemother. 2005 Feb;49(2):866-7. No abstract available.

50.

Bacteriophages and diffusion of beta-lactamase genes.

Muniesa M, García A, Miró E, Mirelis B, Prats G, Jofre J, Navarro F.

Emerg Infect Dis. 2004 Jun;10(6):1134-7.

Supplemental Content

Loading ...
Support Center